Recombinant anti-human melanoma antibodies are versatile molecules

Journal of Investigative Dermatology

Volumn 107, Issue 2, 1996, Pages 164-170

  Neri, Dario ^a   Natali, Pier Giorgio ^b   Petrul, Heike ^a   Soldani, Patrizia ^c   Nicotra, Maria Rita ^d   Vola, Roberto ^e   Rivella, Anna ^e   Creighton, Andrew M ^e   Neri, Paolo ^c   Mariani, Massimo ^f,g  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d CNR   (Italy)

^e Cyberonics Inc   (Italy)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g Immunological Research Institute   (Italy)

Author keywords

Antibody functionalization; Human melanoma; Recombinant antibodies; scFv

Indexed keywords

ANTIBODY;

ARTICLE; DIAGNOSTIC IMAGING; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; MOLECULAR BIOLOGY; PRIORITY JOURNAL;

EID: 9344238841     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12329566     Document Type: Article

References (48)

1. Begent RH, Chester KA, Connors T, Crowther D, Fox B, Griffiths E, Hince TA, Ledermann JA, McVie JG, Minor P, Secher DS, Schwartsmann G, Thorpe R, Wilbin C, Zwierzina H: Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials. Eur J Cancer 29A:1907-1910, 1993
2. Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, Lee T, Pope SH, Riordan GS, Whitlow M: Single-chain antigen-binding proteins. Science 242:423-426, 1988
3. Britton KE, Mather SJ, Granowska M: Radiolabeled monoclonal antibodies in oncology, Part III. Radioimmunotherapy. Nucl Med Commun 12:333-347, 1991
4. 2 fragments. Cancer Res 45:3378-3387, 1985
5. Clackson T, Hoogenboom HR, Griffiths AD, Winter G: Making antibody fragments using phage display libraries. Nature 352:624-628, 1991
6. Crothers DM, Metzger H: The influence of polyvalency on the binding properties of antibodies. Immunochemistry 9:341-357, 1972
7. Cumber AJ, Ward ES, Winter G, Parnell GD, Warzynczak EJ: Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate. J Immunol 149:120-126, 1992
8. Dean RT, Weber R, Pak K, Boutin R, Buttram S, Nedelman M, Lister-James J: New facile method for stably labeling antibodies with technetium-99m. In: Nicolini M, Bandoli G, and Mazzi U (eds.). Technetium and Rhenium in Chemistry and Nuclear Medicine. Raven Press, New York, pp 605-608, 1990
9. Giacomini P, Veglia F, Cordiali Fei P, Rehle T, Natali PG, Ferrone S: Level of a membrane-bound high-molecular weight melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma. Cancer Res 44:1281-1287, 1984
10. Goldenberg DM: Monoclonal antibodies in cancer detection and therapy. Am J Med 94:297-312, 1993
11. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, Kontermann RE, Jones PT, Low NM, Allison TJ, Prospero TD, Hoogenboom HR, Nissim A, Cox JPL, Harrison JL, Zaccolo M, Gherardi E, Winter G: Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 13:3245-3260, 1994
12. Hoogenboom HR, Griffiths AD, Johnson KS, Chiswell DJ, Hudson P, Winter G: Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic. Acids Res 19:4133-4137, 1991
13. Hopp TP, Prickett KS, Price VL, Libby RT, March CJ, Cerretti DP, Urdal DL, Conlon PJ: A short polypeptide marker sequence useful for recombinant protein identification and purification. Biotechnology 6:1204-1210, 1988
14. Howell RW, Goddu SM, Rao DV: Application of the linear-quadratic model to radioimmunotherapy: further support for the advantage of longer-lived radionuclides. J Nucl Med 35:1861-1869, 1994
15. Huston JS, Levinson D, Mudgett HM, Tai MS, Novotny J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E, Crea R, Oppermann H: Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci USA 85:5879-5883, 1988
16. Jönsson U, Fägerstam L, Ivarsson B, Johnsson B, Karlsson R, Lundh K, Löfas S, Persson B, Roos H, Rönnberg I, Sjölander S, Stenberg E, Stählberg, Urbaniczky C, Östlin H, Malmqvist M: Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques 11:620-627, 1991
17. Kihlberg BM, Sjobring U, Kastern W, Bjorck L: Protein LG: a hybrid molecule with unique immunoglobulin binding properties. J Biol Chem 267:25583-25588, 1992
18. King DJ, Turner A, Farnsworth AP, Adair JR, Owens RJ, Pedley RB, Baldock D, Proudfoot KA, Lawson ADG, Beeley NRA, Millar K, Millica TA, Boyce BA, Antoniw P, Mountain A, Begent RHJ, Shochat D, Yarranton GT: Improved tumor targeting with chemically cross-linked recombinant antibody fragments. Cancer Res 54:6176-6185, 1994
19. Kusama M, Tageshit T, Chen ZJ, Ferrone S: Characterisation of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high-molecular weight melanoma-associated antigen monoclonal antibodies. J Immunol 143:3844-3852, 1989
20. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
21. 99mTc. Eur J Nucl Med 22:1326-1329, 1995
22. Mariani M, Bracci L, Presentini R, Nucci D, Neri P, Antoni G: Immunogenicity of a free synthetic peptide: carrier conjugation enhances antibody affinity for the native protein. Mol Immunol 24:297-303, 1987
23. 2 from mouse IgG1. Mol Immunol 28:69-77, 1991
24. Marin O, Meggio F, Marchiori F, Borin G, Pinna LA: Site specificity of casein kinase-2 (TS) from rat liver cytosol. A study with model peptide substrates. Eur J Biochem 160:239-244, 1986
25. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G: By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222:581-597, 1991
26. McCafferty J, Griffiths AD, Winter G, Chiswell DJ: Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552-554, 1990
27. McKearn TJ: Radioimmunodetection of solid tumours. Cancer 71:4302-13, 1993
28. Montigiani S, Neri G, Neri P, Neri D: Alanine substitutions in calmodulin-binding peptides result in unexpected affinity enhancement. J Mol Biol 258:6-13, 1996
29. Munro S, Pelham HRB: An Hsp-like protein in the ER: identity with the 78 kD glucose regulated protein and immunoglobulin heavy chain binding protein. Cell 46:291-300, 1986
30. Natali PG, Bigotti A, Cavaliere R, Nicotra MR, Ferrone S: Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and HLA antigens. J Natl Cancer Inst 73:13-24, 1984
31. Natali PG, Cavaliere R, Bigotti A, Nicotra MR, Russo C, Ng AK, Giacomini P, Ferrone S: Antigenic heterogeneity of surgically removed and primary and autologous metastatic human lesions. J Immunol 130:1462-1466, 1983
32. Neri D, de Lalla C, Petrul H, Neri P, Winter G: Calmodulin as a versatile tag for antibody fragments. Biotechnology 13:373-377, 1995a
33. Neri D, Momo M, Prospero T, Winter G: High-affinity antigen binding by chelating recombinant antibodies (CRAbs). J Mol Biol 246:367-373, 1993b
34. Neri D: Petrul H, Roncucci G: Engineering recombinant antibodies for immunotherapy. Cell Biophys 27:47-61, 1995c
35. 32P]-ATP. Biotechnology 14:485-490, 1996a
36. Neri D, Prospero T, Petrul H, Winter G, Browne M and Vanderpant L: A multi-purpose high sensitivity luminescence analyser (LUANA): use in gel electrophoresis. Biotechniques 20:708-713, 1996b
37. Nissim A, Hoogenboom H, Tomlinson IM, Flynn G, Midgley C, Lane D and Winter G: Antibody reagents from a 'single-pot' phage display library as immunochemical reagents. EMBO J 13:692-698, 1994
38. Pack P, Kujau M, Schroeckh U, Knüpfer R, Wenderoth R, Riesenberg D and Plückthun A: Improved bivalent miniantibodies with identical avidity as whole antibodies produced by high cell density fermentation of Escherichia coli. Biotechnology 11:1271-1277, 1993
39. Paganelli G, Magnani P, Zito F, Villa E, Sudati E, Lopalco L, Rossetti C, Malcovati M, Chiolerio F, Seccamani E, Siccardi AG, Fazio F: Three-step monoclonal antibody tumour targeting in carcinoembryonic antigen-positive patients. Cancer Res 51:5960-5966, 1991
40. Riva P, Arista A, Tison V, Sturiale C, Franceschi G, Spinelli A, Riva N, Casi M, Moscatelli G, Frattarelli M: Intralesional radio-immunotherapy of malignant gliomas. Cancer 73:1076-1082, 1994
41. Siccardi AG, Buraggi GL, Callegaro L, Mariani G, Natali PG, Abbati A, Bestagno M, Caputo V, Mansi L, Masi R, Paganelli G, Riva P, Salvator M, Sanguineti M, Troncone L, Turco GL, Scassellati GA, Ferrone S: Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Cancer Res 46:4817-4822, 1986
42. 99mTc-labelled monoclonal antibody fragments. Eur J Nucl Med 16:317-323, 1987
43. v fragment in Escherichia coli. Science 240:1038-1040, 1988
44. 75)-[6-[4-(N,N-diethylamino)phenyl]-1,3,5-triazin-4-yl-calmodulin interactions with smooth muscle myosin light chain kinase and derived peptides. Biochemistry 33:12807-12820, 1994
45. VanEldik LJ, Lukas TJ: Site-directed antibodies to vertebrate and plant calmodulins. Methods Enzymol 139:393-405, 1987
46. Vola R, Lombardi A, Tarditi L, Zaccolo M, Neri D, Bjorck L, Mariani M: Recombinant proteins 1 and LG: two new tools for purification of murine antibody fragments. Cell Biophys 24/25:27-36, 1994
47. Winter G, Milstein C: Man-made antibodies. Nature 349:293-299, 1991
48. Yokota T, Milenic DE, Whitlow M, Wood JE, Hubert SL, Schlom J: Microautoradiographic analysis of the normal organ distributions of radioiodinated scFv and other immunoglobulin forms. Cancer Res 53:3776-3783, 1993